Where does the money go?
In 2016, Health Canada approved four new drugs for the treatment of myeloma, more than have been approved over the past ten years. Health Canada approval, however, is only the first step in the long process of securing provincial funding for public drug programs.
The Multiple Myeloma March helps to increase awareness and raise funds to drive clinical research and support advocacy, for accelerated access to game-changing therapies for Canadian patients.
An Integrated Approach from Clinical Research to Drug Access